Pharmaceuticals

Novo Nordisk reports positive results from Phase-3 haemophilia B study of N9-GP

Pharmaceutical Business Review feed - 2 hours 5 min ago
Novo Nordisk has reported positive results from Phase-3 study of FIX derivative N9-GP to treat haemophilia B.
Categories: Pharmaceuticals

SciClone, Zensun enter into agreement for Neucardin in China

Pharmaceutical Business Review feed - Fri, 17/05/2013 - 11:30
SciClone Pharmaceuticals has entered into an agreement with Zensun granting SciClone a license and exclusive rights in China, for the promotion and sale of Neucardin.
Categories: Pharmaceuticals

Almac secures BBSRC programme with UCL

Pharmaceutical Business Review feed - Fri, 17/05/2013 - 11:00
UK-based Almac biocatalysis has secured a Biotechnology and Biological Sciences Research Council (BBSRC) programme with University College London (UCL) aimed at metagenomics and novel enzyme discovery.
Categories: Pharmaceuticals

UCB, IBM collaborate on super-computer project to improve epilepsy care

Pharmaceutical Business Review feed - Fri, 17/05/2013 - 11:00
UCB and IBM have announced the completion of the initial phase of project designed to exploit super-computer power for better care for epilepsy patients.
Categories: Pharmaceuticals

Trillium Therapeutics completes dosing in Phase I study of TTI-1612

Pharmaceutical Business Review feed - Fri, 17/05/2013 - 08:34
Trillium Therapeutics, a wholly owned subsidiary of Stem Cell Therapeutics, has completed dosing of patients with interstitial cystitis/bladder pain syndrome (IC/BPS) in first phase study of TTI-1612.
Categories: Pharmaceuticals

Evotec, Harvard to jointly develop new class of antibacterials

Pharmaceutical Business Review feed - Fri, 17/05/2013 - 08:33
Evotec and Harvard University have entered into research collaboration to develop new class of antibacterials.
Categories: Pharmaceuticals

Helsinn, Vifor sign distribution deal for netupitant-palonosetron fixed dose combination

Pharmaceutical Business Review feed - Fri, 17/05/2013 - 06:37
Helsinn Healthcare and Vifor Pharma have signed a licensing and distribution deal for netupitant-palonosetron fixed dose combination (NEPA) in Switzerland, France, Spain, Portugal, the Netherlands, Belgium and Luxembourg.
Categories: Pharmaceuticals

AstraZeneca Issues Update on Accelerated Oncology Pipeline in Advance of 2013 ASCO Annual Meeting

Pharmiweb feed - Fri, 17/05/2013 - 01:00
AstraZeneca Issues Update on Accelerated Oncology Pipeline in Advance of 2013 ASCO Annual Meeting
First patient enrolled in P...
AstraZeneca
Categories: Pharmaceuticals

Bayer to acquire Steigerwald Arzneimittelwerk GmbH

Pharmiweb feed - Fri, 17/05/2013 - 01:00
Bayer to acquire Steigerwald Arzneimittelwerk GmbH
Leverkusen, Germany, May 16, 2013 – Bayer signed an agreement Thursday to ...
Bayer
Categories: Pharmaceuticals

Bristol-Myers Squibb Announces Intention to Voluntarily Delist Preferred Stock

Pharmiweb feed - Fri, 17/05/2013 - 01:00
Bristol-Myers Squibb Announces Intention to Voluntarily Delist Preferred Stock
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squi...
Bristol-Myers Squibb Company
Categories: Pharmaceuticals

EISAI TO PRESENT NEW RESEARCH ON ONCOLOGY PRODUCTS AND PIPELINE AT 49TH ASCO ANNUAL MEETING

Pharmiweb feed - Fri, 17/05/2013 - 01:00
EISAI TO PRESENT NEW RESEARCH ON ONCOLOGY PRODUCTS AND PIPELINE AT 49TH ASCO ANNUAL MEETING
Eisai Co., Ltd.
Eisai Co
Categories: Pharmaceuticals

Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis

Pharmiweb feed - Fri, 17/05/2013 - 01:00
Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
Paris, Franc...
Sanofi
Categories: Pharmaceuticals

Novartis wins GBCHealth Business Action on Health Award for social ventures initiative

Pharmiweb feed - Fri, 17/05/2013 - 01:00
Novartis wins GBCHealth Business Action on Health Award for social ventures initiative
GBCHealth recognizes Novartis Arogya ...
Novartis
Categories: Pharmaceuticals

New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome

Pharmiweb feed - Fri, 17/05/2013 - 01:00
New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs SyndromeUCB
Categories: Pharmaceuticals

Bayer to acquire Steigerwald Arzneimittelwerk

Pharmaceutical Business Review feed - Thu, 16/05/2013 - 23:00
Bayer has signed an agreement to purchase 100% of the shares of Steigerwald Arzneimittelwerk.
Categories: Pharmaceuticals

Alethia gains US patent for cancer treatment methods

Pharmaceutical Business Review feed - Thu, 16/05/2013 - 23:00
Alethia Biotherapeutics has gained US patent for methods of treating carcinomas with antibodies targeting the region of secreted clusterin (sCLU) responsible for promoting epithelial-to-mesenchymal transition (EMT).
Categories: Pharmaceuticals

US government awards antibody development contract to AnaptysBio

Pharmaceutical Business Review feed - Thu, 16/05/2013 - 23:00
The US government has awarded a contract to AnaptysBio for the development of highly thermostable anti-ricin antibodies for biodefense applications.
Categories: Pharmaceuticals

Janssen Biotech announces FDA approval of Simponi ulcerative colitis therapy

Pharmaceutical Business Review feed - Thu, 16/05/2013 - 12:13
Janssen Biotech has announced the FDA approval of Simponi (golimumab) to treat moderately to severely active ulcerative colitis (UC) in adult patients with corticosteroid dependence or an inadequate response to or failed to tolerate oral aminosalicylates, oral corticosteroids, azathioprine, or 6-mercaptopurine.
Categories: Pharmaceuticals

US FDA approves Xofigo as castration-resistant prostate cancer therapy

Pharmaceutical Business Review feed - Thu, 16/05/2013 - 11:59
The US FDA has approved Xofigo (radium Ra 223 dichloride) for the treatment of symptomatic late-stage (metastatic) castration-resistant prostate cancer spread to bones but not to other organs in men.
Categories: Pharmaceuticals

Nuvo Research wins US patent for WF10 drug candidate

Pharmaceutical Business Review feed - Thu, 16/05/2013 - 11:56
Canada-based pharmaceutical company Nuvo Research has received US Patent relating to compositions and methods of using WF10 and new derivative formulations for the treatment of allergic asthma, allergic rhinitis and atopic dermatitis.
Categories: Pharmaceuticals
123456789…next ›last »

The Bottom Line:If Mr Cable has his way...

"If Mr Cable had his way, all the big banks would be broken up and bonuses would be virtually eliminated - a sure-fire way in my view of guaranteeing an end to the UK’s ability to compete as an international financial centre. Let’s not forget that this is a man who is on record as saying that everyone who works in a bank has an ‘aristocratic lifestyle’ clearly demonstrating his lack of understanding of the sector." A tough line on bankers’ bonuses could make a brain drain of financial talent a distinct possibility, warns Paul Marsden. Read more